'' '' '' ''
![]() |
PRINT ISSN : 2319-7692 Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com / submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
Presently, the known gamma-retroviruses, Xenotropic Murine Leukemia virus (MLV) -related Virus (XMRV) is imminent as a cancer causing infectious virus in prostate cancer. This study has been designed on retrovirus (XMRV) infection in Indian PCa patient and its co-relation with clinical pathological and demographic parameters of prostate cancer cases and Benign Prostate hyperplasia (BPH) as controls. A total of 235 prostate samples including 105 confirmed prostate cancer cases and 130 benign prostate hyperplasia (BPH) as controls were analyzed for XMRV infection. We have used Nested –PCR method for XMRV detection followed by sequencing. Statistical analysis was done by Graphpad Instat version 3.3 for co-relation between XMRV status and clinical pathological parameters of prostate cancer cases and BPH controls. Out of 235 prostate samples, XMRV was detected 5.4% (7/130) in BPH tissue samples and 7.6% (8/105) in PCa tissue samples. Patients with higher PSA level were found to prone for XMRV infection in both PCa as well as BPH samples with non significant statistical correlation (p˃0.05). We found no significant correlation with other clinical parameter like Gleason score (p=0.72), histological grading (p=0.82) and tumor stages I-IV (p=0.31). This study does not support the evidence of XMRV infection in prostate cancer initiation and development in Indian population. Clearly, decision of this discrepancy will require more information and investigation with larger sample size.
![]() |
![]() |
![]() |
![]() |
![]() |